Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: an extension of the Psoriatic Arthritis Cost Evaluation (PACE) study

Olivieri I.; Cortesi P. A.; de Portu S.; Salvarani C.; Cauli A.; Lubrano E.; Spadaro A.; Cantini F.; Ciampichini R.; Cutro M. S.; Mathieu A.; Matucci-Cerinic M.; Punzi L.; Scarpa R.; Mantovani L. G.

首页> 外文期刊>Clinical and experimental rheumatology >Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: an extension of the Psoriatic Arthritis Cost Evaluation (PACE) study

【24h】

Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: an extension of the Psoriatic Arthritis Cost Evaluation (PACE) study

机译：对使用肿瘤坏死因子抑制剂治疗的传统疗法无反应的银屑病关节炎患者的长期成本和结局：银屑病关节炎成本评估（PACE）研究的扩展

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective

机译：目的

著录项

来源
《Clinical and experimental rheumatology》 |2016年第1期|共8页
作者
Olivieri I.; Cortesi P. A.; de Portu S.; Salvarani C.; Cauli A.; Lubrano E.; Spadaro A.; Cantini F.; Ciampichini R.; Cutro M. S.; Mathieu A.; Matucci-Cerinic M.; Punzi L.; Scarpa R.; Mantovani L. G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
psoriatic arthritis; anti-tumour necrosis factor agents; costs; quality of life;

机译：银屑病关节炎;抗肿瘤坏死因子药物;费用;生活质量;

相似文献

外文文献
中文文献
专利

1. Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: an extension of the Psoriatic Arthritis Cost Evaluation (PACE) study [J] . Olivieri I., Cortesi P. A., de Portu S., Clinical and experimental rheumatology . 2016,第1期

机译：对使用肿瘤坏死因子抑制剂治疗的传统疗法无反应的银屑病关节炎患者的长期成本和结局：银屑病关节炎成本评估（PACE）研究的扩展
2. The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. [J] . Olivieri I, de-Portu S, Salvarani C, Rheumatology . 2008,第11期

机译：银屑病关节炎成本评估研究：一项对传统疗法反应不足的银屑病关节炎患者中肿瘤坏死因子抑制剂的疾病成本研究。
3. Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis [J] . Genovese Mark C., Weinblatt Michael E., Mease Philip J., Rheumatology . 2018,第11期

机译：ABT-122的肿瘤坏死因子和白细胞介素-17a的双重抑制：类风湿性关节炎或银屑病关节炎的开放标签长期延伸研究
4. Psoriatic arthritis Clinical improvement and correlation with hormone axes in etanercept-treated patients [C] . Fabiola Atzeni, Rainer H. Straub, Maurizio Cutolo, International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases . 2010

机译：依托西普治疗患者患者临床改善及与激素轴相关性
5. Costs, quality of life and mortality outcomes in United States rheumatoid arthritis patients. [D] . Michaud, Kaleb Dean. 2006

机译：美国类风湿关节炎患者的成本，生活质量和死亡率结果。
6. The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy [O] . I. Olivieri, S. de Portu, C. Salvarani, -1

机译：银屑病关节炎成本评估研究：对传统疗法反应不足的银屑病关节炎患者中肿瘤坏死因子抑制剂的疾病成本研究
7. PMS64 Long Term Costs and Outcomes in Psoriatic Arthritis Patients Not Responding to Conventional Therapy Treated with Tumor Necrosis Factor Inhibitors: The Extension of Psoriatic Arthritis Cost Evaluation (PACE) Study [O] . Cortesi P.A., Olivieri I., de Portu S., 2013

机译：PMS64牛皮癣关节炎患者的长期费用和结果对用肿瘤坏死因子抑制剂治疗的常规疗法无反应：牛皮癣关节炎费用评估（PACE）研究的扩展

Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: an extension of the Psoriatic Arthritis Cost Evaluation (PACE) study

摘要

著录项

相似文献

相关主题

期刊订阅